Participate in MDMA Studies

We are currently recruiting for the Phase 3 study of MDMA-assisted psychotherapy for PTSD. Here is a list of all MAPS-sponsored trials on clinicaltrials.gov.

Become a Therapy Provider

Applications are open for practitioners and sites interested in providing limited MDMA therapy within a clinical trial setting.

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Publications

The Lancet: Psychiatry

MDMA-assisted psychotherapy for PTSD in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.

Psychopharmacology: Pooled CAPS Study

Here we evaluate six phase 2 trials in a pooled analysis to determine the study design for phase 3 trials of MDMA-assisted psychotherapy for PTSD. MDMA-assisted psychotherapy was efficacious and well tolerated in a large sample of adults with PTSD.

All Studies

Learn more about all of our completed, ongoing and planned studies, and see all of our publications on our Study Information page.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Careers
News
FAQ
Contact Us

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.